Clinical Trial Update: Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating MN-221 as an adjunct to standard therapy in adults experiencing an acute asthma exacerbation has been completed, assessing safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MN-221

Snippet

Sponsor: MediciNova | Conditions: Asthma | Phase 2 | Status: COMPLETED